Related references
Note: Only part of the references are listed.Missense Mutations in PBP2A Affecting Ceftaroline Susceptibility Detected in Epidemic Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clonotypes ST228 and ST247 in Western Switzerland Archived since 1998
William L. Kelley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ceftobiprole- and Ceftaroline-Resistant Methicillin-Resistant Staphylococcus aureus
Liana C. Chan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
S. Wesley Long et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective
Richard A. Alm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics
Jennifer Fishovitz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
A Shared Population of Epidemic Methicillin-Resistant Staphylococcus aureus 15 Circulates in Humans and Companion Animals
Ewan M. Harrison et al.
MBIO (2014)
Incidence and Characterisation of Methicillin-Resistant Staphylococcus aureus (MRSA) from Nasal Colonisation in Participants Attending a Cattle Veterinary Conference in the UK
Gavin K. Paterson et al.
PLOS ONE (2013)
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function
Lisandro H. Otero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline
Rodrigo E. Mendes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Share Paper
